Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has purchased 589,000 of its ordinary shares on the London Stock Exchange between August 3rd and August 7th, 2026, as part of its $250 million share repurchase program. The average price paid was approximately 1,680.96 pence per share. The company intends to cancel these repurchased shares, and following these transactions, Hikma will have 209,572,695 ordinary shares in issue.

Disclaimer*

UK 100

Latest directors dealings